US Stock MarketDetailed Quotes

KPTI Karyopharm Therapeutics

Watchlist
  • 0.911
  • +0.021+2.38%
Close Jul 22 16:00 ET
  • 0.900
  • -0.011-1.23%
Post 17:54 ET
113.55MMarket Cap-717P/E (TTM)

Karyopharm Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Karyopharm Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 8, 2024

Revenue(YoY)

33.13M

-14.40%
EPS(YoY)

-0.32

-6.67%
Analyst Rating

Strong Buy

Jul 22, 2024

Karyopharm Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 37.705M--
--2024/Q2-- / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--
Feb 29, 20242023/Q433.747M / 33.616M--
Nov 2, 20232023/Q336.009M / 37.403M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 37.705M--
--2024/Q2-- / 36.213M--
May 8, 20242024/Q133.126M / 34.473M--
Feb 29, 20242023/Q433.747M / 33.616M--
Nov 2, 20232023/Q336.009M / 37.403M--

Unlock Free Earnings Estimates

Karyopharm Therapeutics Earnings Reports

  • Karyopharm Therapeutics | 10-Q: Quarterly report

    May 8 17:18 ET

  • Karyopharm Therapeutics | 10-K: Annual report

    Feb 29 07:48 ET

  • Karyopharm Therapeutics | 10-Q: Q3 2023 Earnings Report

    Nov 2, 2023 07:57 ET

  • Karyopharm Therapeutics | 10-Q: Q2 2023 Earnings Report

    Aug 2, 2023 07:48 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 22, 2024

    Strong Buy

    • Buy

      80.00%

    • Hold

      20.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg